EBITDA: Income before interest, taxes, depreciation and amortization.
NeuroSense Therapeutics Ltd. (NRSN) EBITDA data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.56M |
|
$0.06M |
|
$0.13M |
|
$1.68M |
|
$2.20M |
|
-- |
|
-- |
|
$2.20M |
|
$-0.52M |
|
$-0.52M |
|
$-0.52M |
|
24.60M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
$-0.01M |
|
$1.30M |
|
$3.38M |
|
$0.67M |
|
$-2.71M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|